Day One Biopharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $53,718 | $39,795 | $33,908 | $30,761 |
Gross Profit | 47,637 | 35,315 | 30,143 | 27,877 |
EBITDA | -22,575 | -18,787 | -29,358 | -35,102 |
EBIT | -23,254 | -19,726 | -30,322 | -35,996 |
Net Income | -21,278 | -19,726 | -30,322 | -35,996 |
Net Change In Cash | 53,718 | 39,795 | 33,908 | 30,761 |
Free Cash Flow | -17,649 | -5,805 | -21,309 | -62,814 |
Cash | 197,078 | 43,277 | 35,622 | 33,358 |
Basic Shares | 103,381 | 103,381 | 103,069 | 102,710 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $158,182 | $131,161 | $0 | $0 |
Gross Profit | 140,972 | 125,882 | -383 | -531 |
EBITDA | -105,822 | -86,323 | -188,534 | -146,378 |
EBIT | -109,298 | -88,352 | -188,917 | -146,909 |
Net Income | -107,322 | -95,496 | -188,917 | -132,176 |
Net Change In Cash | 158,182 | 131,161 | 0 | 0 |
Cost of Revenue | -199,047 | |||
Free Cash Flow | -104,077 | -80,282 | -150,077 | -109,900 |
Cash | 197,078 | 124,968 | 230,784 | 85,262 |
Basic Shares | 103,381 | 93,623 | 79,773 | 65,466 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.21 |
2025-09-30 | -$0.19 |
2025-06-30 | -$0.29 |
